FDA Guidance for Industry: Self-Identification of Generic Drug Facilities, Sites, and Organizations

Title:
FDA Guidance for Industry: Self-Identification of Generic Drug Facilities, Sites, and Organizations
Origin/Publisher:

FDA, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM316672.pdf

Content:
This guidance is intended to assist human generic drug facilities, sites, and organizations by describing how the FDA will implement an identification requirement contained in the Generic Drug User Fee Amendments of 2012

Go back